Andrew Rothstein
Optometrist · Birmingham, ALNPI 1528440955
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 20.4%. 2023 is the largest year on record at $343, 3.2 times the $107 reported in 2019. That places this record below the midpoint for optometrist clinicians in AL, where the typical reported total is $902.
Across 25 payments — averaging $29.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$150
- Johnson & Johnson Vision Care, Inc.$150
- Aerie Pharmaceuticals, Inc.$103
- Coopervision Inc.$100
- Bausch & Lomb, A Division Of Bausch Health US, LLC$91
- Biotissue Holdings Inc.$84
- plus $57 from 3 others
What the payments were for
- Consulting fees$25034%
- Speaking & faculty fees$15020%
- Food & beverage$33445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 3 | $150 |
| Johnson & Johnson Vision Care, Inc. | 3 | $150 |
| Aerie Pharmaceuticals, Inc. | 6 | $103 |
| Coopervision Inc. | 2 | $100 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $91 |
| Biotissue Holdings Inc. | 3 | $84 |
| Novartis | 2 | $27 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
How this compares
$734 in reported general payments places this provider in the 45th percentile of 749 optometrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 37 | $455 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Birmingham
- Kelly NicholsBirmingham$231K
- Leo SemesBirmingham$60K
- Andrew PuckerBirmingham$27K
- Ashley SavageBirmingham$9K
- Ami EpsteinBirmingham$8K
- Caroline PateBirmingham$6K
- Casey BrownBirmingham$5K
- Valencia WellsBirmingham$5K
- Nicholas OnkenBirmingham$5K
- Mark SchaefferHoover$470K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.